Insights

The controversy surrounding the FDA's recent approvals of medications for Alzheimer’s disease has raised important questions about the medications’ safety and cost, as well as their ability to delive... read more

Congress negotiates its year-end healthcare package, Dreamers lose access to ACA exchanges, and Elevance reverses its controversial anesthesia policy. read more

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures. read more

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again. read more

As clinical and non-clinical AI use cases increase, our experts offer advice to help providers feel more confident as they venture into this brave new world. read more

For many healthcare systems, the 340B Drug Pricing Program can be a saver ... and a stressor. That’s why systems like Intermountain Health have devoted centralized resources to helping their more tha... read more

CMS finalizes the 2025 OPPS rule, an appeals court rules reverses a No Surprises Act decision, and MACPAC calls for more Medicaid payment oversight. read more

The FTC finalizes its premerger notification rule, Walgreens announces over 1K closures, and providers win a large antitrust class action settlement. read more

VP Harris proposes that Medicare cover home health aides, four health systems launch a new company, and CMS releases its initial list for $2 generic drugs. read more

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation. read more